Koyfin Home > Directory > Health Care > Antares Pharma > Return on Equity %

Antares Pharma Return on Equity % Chart (ATRS)

Antares Pharma annual/quarterly Return on Equity % from 2001 to 2018.
  • Antares Pharma Return on Equity % for the quarter ending December 12, 2018 was 77.43 a 203.55% increase of 157.61 year over year
  • Antares Pharma Return on Equity % for the last 12 months ending December 12, 2018 was -17.96 a -190.98% increase of 34.30 year over year
  • Antares Pharma Annual Return on Equity % for 2018 was -17.96 a -136.71% increase of 24.55 from 2017
  • Antares Pharma Annual Return on Equity % for 2017 was -42.51 a -1.99% increase of 0.85 from 2016
  • Antares Pharma Annual Return on Equity % for 2016 was -43.36 a 11.97% decrease of -5.19 from 2015
Other Margins & Efficiency Metrics:
  • Antares Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-27m a -45.38% increase of 12m year over year
  • Antares Pharma Return on Capital % for the quarter ending December 12, 2018 was -25.15 a -0.12% increase of 0.03 year over year
View Chart On Koyfin

Quarterly ATRS Return on Equity % Data

12/201877.43
09/2018-31.60
06/2018-68.36
03/2018-80.18
12/2017-42.73
09/2017-57.19
06/2017-27.81
03/2017-43.74
12/2016-38.20
09/2016-47.28

Annual ATRS Return on Equity % Data

2018-17.96
2017-42.51
2016-43.36
2015-38.17
2014-62.82
2013-26.08
2012-19.42
2011-23.23
2010-78.71
2009-127.88